Sonovia has raised US$10 million through an IPO
December 2020 — Sonovia Ltd. has raised funds to refinance and develop the company.
Sonovia’s ground-breaking technology SonoFinishing™ helps to keep away bacteria, viruses and fungi of all kinds. It has been perfected over the years and proven in labs around the world. The company offers a commercial solution that eliminates the need for chemical binders, polymers, plastics and other harmful chemicals, and dramatically reduces the consumption of water in the process, yielding reusable and practical products and services at competitive prices.
Our role in the transaction
Oaklins’ team in Israel advised the company and acted as the leader of the distributors’ consortium.
Talk to the deal team
Related deals
Life & Mobility has attracted investor Bolster Investment Partners
Life & Mobility, a leading developer and manufacturer of premium mobility and rehabilitation solutions, has welcomed Bolster Investment Partners as a new shareholder. The partnership provides Life & Mobility with a strong long-term partner to support the company’s next phase of growth, with a continued focus on product innovation, strengthening its leading market position and further international expansion. The company’s mission remains to enhance the mobility, independence and quality of life of end users through innovative, sustainable and circular mobility solutions designed for multiple life cycles.
Learn moreSynergia and Bolster have secured acquisition financing for Life & Mobility
Synergia Capital Partners and Bolster Investment Partners have partnered with Life & Mobility, a leading Dutch developer and manufacturer of premium mobility and rehabilitation solutions. The partnership marks an important next step in Life & Mobility’s growth trajectory, focused on further international expansion, continued product innovation and strengthening its leading market position.
Learn more7BidCo has completed the sell-out procedure for the shares of STAR7
7BidCo S.p.A. has completed the sell-out procedure for 8.5% of STAR7 S.p.A.’s shares.
Learn more